ZILBRYSQ (zilucoplan)

Zilbrysq is a complement inhibitor recommended by healthcare professionals for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.

Note: Zilbrysq (Zilucoplan) is an FDA-approved drug.

• Life-threatening and fatal meningococcal infections have occurred in both vaccinated and unvaccinated patients treated with complement inhibitors; ZILBRYSQ is a complement inhibitor. The use of ZILBRYSQ increases a patient’s susceptibility to serious and life-threatening meningococcal infections (septicemia and/or meningitis) caused by any serogroup, including non-groupable strains. Closely monitor patients for early signs and symptoms of meningococcal infection and evaluate patients immediately if infection is suspected. Withhold administration of ZILBRYSQ in patients who are undergoing treatment for meningococcal infection until the infection is resolved 
  
• Pancreatitis and pancreatic cysts have been reported in patients treated with ZILBRYSQ. Discontinue ZILBRYSQ in patients with suspected pancreatitis and initiate appropriate management until pancreatitis is ruled out or has resolved.
  

What documents are required to import Zilbrysq to India?

Zilbrysq( Zilucoplan) can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patient ID proof (issued by the government of India)

The order will be confirmed only after the receipt of:

• Valid prescription of Doctor
  
• Import permit, if applicable

Zilbrysq is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
  
• Medicine Price.
  
•  Finding Genuine and reliable sources from Canada, Europe, the USA, and Australia
  
• Ensuring 100% transparency.

 Indian Pharma Network can facilitate the supply of Zilbrysq (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable). 

 Please contact or mail @ – info@indianpharmanetwork.in +91 9310090915- Toll-Free – 1800-889-1064 for Zilbrysq price in India. 

 We guarantee quality and delivery anywhere in the world as per the buyer’s requirements. 

Indian Pharma Network is able to source the Zilbrysq Injection (immunosuppressant) from across the globe, and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

 Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

Indian Pharma Network helps to connect patients with potential distributors, wholesalers, suppliers and dealers of Zilbrysq in India.

What is the mechanism of action of Zilbrysq?

Zilucoplan binds to the complement protein C5 and inhibits its cleavage to C5a and C5b, preventing the generation of the terminal complement complex, C5b-9. The precise mechanism by which zilucoplan exerts its therapeutic effect in generalised myasthenic gravis is unknown but is presumed to involve the reduction of C5b-9 deposition at the neuromuscular junction.

What are the side effects of Zilbrysq?

The common side effects of Zilbrysq are injection site reactions, upper respiratory tract infection, and diarrhea.

What is the price of Zilbrysq in India?

To know the Zilbrysq price in India, you can call or WhatsApp +91-9310090915 or email info@indianpharmanetwork.in.